HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koichi Seto Selected Research

Z-360

10/2011CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells.
10/2010Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 β production in a cancer-induced pain model in mice.
1/2010Pharmacological evaluation of analgesic effects of the cholecystokinin2 receptor antagonist Z-360 in mouse models of formalin- and cancer-induced pain.
1/2010Z-360, a novel cholecystokinin-2/gastrin receptor antagonist, inhibits gemcitabine-induced expression of the vascular endothelial growth factor gene in human pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koichi Seto Research Topics

Disease

4Pancreatic Neoplasms (Pancreatic Cancer)
10/2011 - 01/2010
3Neoplasms (Cancer)
03/2015 - 01/2010
2Pain (Aches)
10/2010 - 01/2010
1Infections
09/2020
1COVID-19
09/2020
1Neoplasm Metastasis (Metastasis)
01/2014
1Lymphatic Metastasis
01/2014
1Melanoma (Melanoma, Malignant)
01/2014
1Carcinogenesis
10/2011
1Hypoxia (Hypoxemia)
10/2011
1Cancer Pain
01/2010
1Adenocarcinoma
01/2010

Drug/Important Bio-Agent (IBA)

4Z-360IBA
10/2011 - 01/2010
3GemcitabineFDA Link
10/2011 - 01/2010
3Cholecystokinin B ReceptorIBA
10/2011 - 01/2010
2specific substance maruyama (Z-100)IBA
03/2015 - 01/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2011 - 01/2010
2Pharmaceutical PreparationsIBA
10/2010 - 01/2010
2Analgesics (Analgesic Drugs)IBA
10/2010 - 01/2010
2Cholecystokinin (Pancreozymin)IBA
01/2010 - 01/2010
1AntibodiesIBA
09/2020
1Immunoglobulin G (IgG)IBA
09/2020
1Immunoglobulin M (IgM)IBA
09/2020
1Granzymes (Granzyme)IBA
01/2014
1Proteins (Proteins, Gene)FDA Link
01/2014
1GastrinsIBA
10/2011
1Ephrin-B1 (Ephrin B1)IBA
10/2010
1Opioid Analgesics (Opioids)IBA
10/2010
1SincalideFDA Link
10/2010
1Interleukin-1 (Interleukin 1)IBA
10/2010
1Tyrosine (L-Tyrosine)FDA Link
10/2010
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2010
1DevazepideIBA
10/2010
1Formaldehyde (Formol)FDA Link
01/2010
1Cholecystokinin A ReceptorIBA
01/2010
1Morphine (MS Contin)FDA LinkGeneric
01/2010

Therapy/Procedure

2Therapeutics
10/2011 - 10/2010
1Immunotherapy
03/2015
1Intraperitoneal Injections
10/2010
1Oral Administration
01/2010